Lipocine Inc. — Director's Dealing 2019

May 28, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Lipocine Inc. (LPCN)
CIK: 0001535955
Period of Report: 2019-05-24

Reporting Person: Patel Mahesh V. (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-05-24	Common Stock	A	4527	$1.58	Acquired	726639	Direct
2019-05-24	Common Stock	A	2500	$1.59	Acquired	729139	Direct
2019-05-24	Common Stock	A	473	$1.60	Acquired	729612	Direct
2019-05-24	Common Stock	A	2500	$1.64	Acquired	732112	Direct